Two nrdF genes, nrdF1 and nrdF2, encoding the small subunit (R2) of ribonucleotide reductase (RR) from Mycobacterium tuberculosis have 71% identity at the amino acid level and are both highly homologous with Salmonella typhimurium R2F. The calculated molecular masses of R2-1 and R2-2 are 36,588 (322 amino acids [aa]) and 36,957 (324 aa) Da, respectively. Western blot analysis of crude M. tuberculosis extracts indicates that both R2s are expressed in vivo. Recombinant R2-2 is enzymatically active when assayed with pure recombinant M. tuberculosis R1 subunit. Both ATP and dATP are activators for CDP reduction up to 2 and 1 mM, respectively. The gene encoding M. tuberculosis R2-1, nrdF1, is not linked to nrdF2, nor is either gene linked to the gene encoding the large subunit, M. tuberculosis nrdE. The gene encoding MTP64 was found downstream from nrdF1, and the gene encoding alcohol dehydrogenase was found downstream from nrdF2. A nrdA(Ts) strain of E. coli (E101) could be complemented by simultaneous transformation with M. tuberculosis nrdE and nrdF2. An M. tuberculosis nrdF2 variant in which the codon for the catalytically necessary tyrosine was replaced by the phenylalanine codon did not complement E101 when cotransformed with M. tuberculosis nrdE. Similarly, M. tuberculosis nrdF1 and nrdE did not complement E101. Activity of recombinant M. tuberculosis RR was inhibited by incubating the enzyme with a peptide corresponding to the 7 C-terminal amino acid residues of the R2-2 subunit. M. tuberculosis is a species in which a nrdEF system appears to encode the biologically active species of RR and also the only bacterial species identified so far in which class I RR subunits are not arranged on an operon.
Mycobacterium tuberculosis is an aerobic, gram-positive bacterium containing a high-GϩC-content genome of approximately 4 ϫ 10 6 bp with a relatively long mean generation time of 24 h and a chromosomal replication time (C period) of 11 h (13) . M. tuberculosis can remain in a dormant, nonreplicating state in the human host for years and can be reactivated to cause disease under certain immunological and/or environmental conditions (38) . The molecular mechanisms that govern these growth patterns and the regulation of DNA synthesis during these growth phases are now the focus of several lines of investigation. DNA polymerase I (14) , topoisomerase I (42) , and gyrA and gyrB (21, 33) from M. tuberculosis have been cloned and sequenced. In addition, the origins of replication of M. tuberculosis, M. smegmatis, and M. leprae have been analyzed and shown to contain a typical gram-positive pattern of genes, rnpA-rpmH-dnaA-dnaN-recF-gyrB-gyrA (28) . Recently, ribonucleotide reductase (RR), potentially the rate-limiting step in DNA replication, was purified from M. tuberculosis, and the gene encoding the large subunit (R1) was isolated, sequenced, and expressed in Escherichia coli (41) .
The enzymatic reduction of ribonucleotides by RR regulates the deoxynucleotide precursor pool for DNA synthesis in a wide variety of bacteria and eukaryotes and in several viruses (12) . Class I RRs are allosteric enzymes composed of two large subunits (R1) which contain substrate and allosteric regulatory sites and two small subunits (R2) which contain a -oxo bridged iron(III)/tyrosyl radical redox center (8, 27) . The enzyme is also regulated at the transcriptional, translational, and posttranslational levels (7, 18, 35, 36) . The redox reaction is coupled to a small redoxin carrier protein, e.g., thioredoxin or glutaredoxin, which is reduced by a second enzyme system, e.g., thioredoxin reductase or glutathione reductase. Thioredoxin and thioredoxin reductase in mycobacteria have been described recently (39) . These reactions are ultimately coupled to NADP/NADPH. Much of the work elucidating the catalytic mechanism of RR as well as the X-ray structure of the subunits has been carried out on the E. coli nrdAB system (2, 23, 37) .
It has recently been shown that Salmonella typhimurium and E. coli contain another set of chromosomal genes, nrdEF, encoding a separate class I RR that is not expressed under normal growth conditions (16) (17) (18) . Lactococcus lactis, an anaerobic gram-positive organism, contains nrdD/nrdG genes which presumably encode an anaerobic class III, iron-sulfur, glycyl radical RR system. L. lactis also contains a nrdEF system which can complement a nrdD L. lactis mutant under conditions where a small amount of residual oxygen in the culture system establishes the tyrosyl radical in the nrdF gene product (19) .
M. tuberculosis is the only organism yet described in which the nrdEF system appears to encode the biologically active form of RR (41) . M. tuberculosis R1 contains the 5 cysteines thought to play a role in the reduction reaction but is otherwise only distantly related to the E. coli and mammalian R1 subunits. Sequence analysis of the gene encoding the M. tuberculosis R1 subunit revealed that it is closely related to nrdE of S. typhimurium and E. coli. There is no PCR or Southern blot evidence for a nrdAB system in M. tuberculosis. We have now (i) cloned and expressed the genes encoding the M. tuberculosis RR small subunit, (ii) determined the genetic organization of the genes encoding the two subunits, (iii) reconstituted enzymatically active recombinant M. tuberculosis RR, (iv) carried out comparative enzyme inhibition studies, and (v) developed a complementation system in which an E. coli strain in which RR is temperature sensitive is rescued at the nonpermissive temperature with transfected M. tuberculosis RR genes.
MATERIALS AND METHODS
Restriction enzymes were purchased from New England BioLabs. pET-11a and BL21(DE3) competent cells were obtained from Novagen. A DEAE-cellulose anion exchanger and 3,3Ј-diaminobenzidine were obtained from Sigma. Protein concentrations were determined by the method of Bradford (3) . M. tuberculosis DNA and irradiated M. tuberculosis were provided by P. J. Brennan, Department of Microbiology, Colorado State University. Pure recombinant M. tuberculosis R2-2 was used to generate polyclonal rabbit anti-M. tuberculosis R2 antibodies (Cocalico Biologicals, Inc., Reamstown, Pa.). An ABC Vectastain kit was purchased from Vector Laboratories. Peptides were purchased from SynPep, Dublin, Calif.
Isolation of partial R2 sequences. Two sets of PCR primers were used to isolate fragments of M. tuberculosis R2 genes. One set (N and C1 primers) consisted of a 5Ј primer (N), 5Ј-TTCATGGAGGC(G/C)GT(G/C)CA-3Ј, corresponding to amino acid positions F 96 MEAVH 101 in S. typhimurium R2F and a 3Ј primer (C1), 5Ј-TAGAACAGGAA(G/C)GACTC-3Ј, corresponding to E 158 SFLFY 163 . The other set (N and C2 primers) consisted of the same 5Ј primer as in the first set and a 3Ј primer (C2), 5Ј-TG(G/C)AC(G/C)GCCTCGTC, corresponding to S. typhimurium R2F amino acid residues D 181 EAVH 185 . The PCRs were carried out in 100 l of a solution which contained 0.25 g of M. tuberculosis genomic DNA (Erdman strain), 100 pmol of primers, all four deoxynucleoside triphosphates (dNTPs) (each 0.2 mM), 10 l of 10ϫ PCR buffer (Perkin-Elmer), and 2.5 U of Taq polymerase (Perkin-Elmer). The reactions were conducted in 30 cycles with the following program: 20 s at 94°C, 30 s at 48°C, and 30 s at 72°C. The 200-bp PCR product from the N and C1 primer reaction and the 300-bp PCR product from the N and C2 primer reaction were purified from an agarose gel with Qiaex silica gel particles (Qiagen), subcloned, and sequenced.
Southern analysis. M. tuberculosis DNA (Erdman strain) (1 g for each reaction) was digested with EcoRI, NotI, SacI, or XbaI in a final volume of 10 l at 37°C overnight. The digested mixture was separated on a 0.7% agarose gel (20 cm) at 70 V for 6 h in 1ϫ Tris-borate-EDTA buffer. The DNA was transferred onto a nylon membrane, dried at 80°C for 2 h, and prehybridized with 25 ml of hybridization mixture (50% formamide, 5ϫ SSPE [1ϫ SSPE is 0.18 M NaCl, 10 mM NaH 2 PO 4 , and 1 mM EDTA {pH 7.7}], 0.1% sodium dodecyl sulfate [SDS], and 0.25% dry milk) at 42°C for 1 h. The 200-bp PCR product radiolabeled with 32 P (probe 1) was added directly to the hybridization bag, and hybridization was continued for 48 h at 42°C. After the film was developed, the membrane was stripped and reprobed with the 32 P-labeled 300-bp PCR product (probe 2). PCR analysis of M. tuberculosis strains. Specific PCR primers for nrdF1 (NTerm: 5Ј ATG ACC GGC AAG CTC GTT GAG 3Ј; CTerm: 5Ј GGT GGT GGG TTG GTG GGT GCC 3Ј) and for nrdF2 (NTerm: 5Ј GTG ACT GGA AAC GCA AAG CTA 3Ј; CTerm: 5Ј GAC GAC CGC CTT GCC GAT CAC 3Ј) were used in PCRs carried out in 100 l of a solution containing 10 ng of genomic DNA (strains CSU 11, CSU 17, CSU 20, CSU 22) or 10 ng of expression plasmid, 1 M each primer, 0.2 mM each dNTP, 1ϫ Vent polymerase buffer, and 2 U of Vent polymerase for 20 cycles of 20 s at 94°C, 20 s at 60°C, and 30 s at 72°C.
Construction of size-selected M. tuberculosis libraries. M. tuberculosis DNA (Erdman strain) (10 g) was digested with SacI (for R2-1) or EcoRI (for R2-2) in the corresponding buffer in a final volume of 100 l at 37°C overnight. The digested DNA was then separated by agarose gel electrophoresis under the same conditions as were used for Southern analysis. The 4-kb SacI fragment and the 6-kb EcoRI fragment (see Fig. 1 ) were purified with Qiaex silica gel and ligated to the correspondingly prepared Lambda ZAP II vectors (Stratagene). E. coli XL1-Blue was infected with the recombinant phage preparations and screened with either probe 1 or probe 2. Positive plaques were picked, and the recombinant phagemids were excised and used to transform XL1-Blue. The phagemids were purified, and the sequences of the inserts were determined.
Expression of M. tuberculosis R2-1 and R2-2. Full-length M. tuberculosis R2-1 was isolated from M. tuberculosis genomic DNA (Erdman strain) by PCR using primers constructed with XbaI cloning sites (underlined) (5Ј primer, 5Ј-TCTA GAATGACCGGCAAGCTCGTTG-3Ј; 3Ј-primer, 5Ј-TCTAGATTAGAAGT CCCAGTCGGTG-3Ј). Full-length M. tuberculosis R2-2 was isolated from recombinant phagemid DNA containing the 6-kb insert by PCR using primers constructed with NheI cloning sites (underlined) (5Ј primer, 5Ј-GCTAGCGTGA CTGGAAACGCAAAG-3Ј; 3Ј primer, 5Ј-GCTAGCCTAGAAGTCCCAGTCA TC-3Ј). The PCR was carried out in 30 cycles of the following program: 20 s at 94°C, 20 s at 54°C, and 3 min at 72°C. The PCR product was gel purified with GenElute Agarose Spin Column (Supelco) and cloned into the pCR vector (Invitrogen). The recombinant plasmid was then transformed into OneShot bacteria, purified, and digested with XbaI (for M. tuberculosis R2-1) or NheI (for M. tuberculosis R2-2). The excised M. tuberculosis R2-1 or R2-2 gene was again gel purified and cloned into the NheI-linearized pET-11a plasmid. BL21(DE3) competent cells were transformed, grown to an optical density at 600 nm of 0.4 to 0.6 at 37°C, and induced with 0.4 mM isopropyl-␤-D-thiogalactopyranoside (IPTG) for an additional 2.5 h.
Purification of recombinant M. tuberculosis R2-2. Recombinant E. coli cell paste (3 g) was suspended in 30 ml of 50 mM Tris-HCl-0.1 mM dithiothreitol (pH 7.5) (buffer A) containing 2 mM phenylmethylsulfonyl fluoride and lysed in a French press. The cell debris was removed by centrifugation at 23,000 ϫ g for 20 min. A solution of 10% streptomycin sulfate in buffer A was added to the supernatant to a final concentration of 0.5% with stirring to precipitate DNA and rRNA. The precipitate was removed by centrifugation (at 23,000 ϫ g for 20 min). Solid ammonium sulfate was slowly added to the supernatant to 60% saturation with stirring. After the addition was complete, the suspension was stirred for 10 min and the precipitate was collected by centrifugation (at 23,000 ϫ g for 20 min). The pellet was resuspended in 5 ml of buffer A and dialyzed against the same buffer for 5 h with one buffer change. After removal of insoluble protein by centrifugation (at 5,000 ϫ g for 10 min), the dialysate was loaded onto a DE52 column (1 by 6 cm) which was preequilibrated with buffer A. The column was washed with 20 ml of buffer A containing 100 mM KCl followed by 15 ml of buffer A containing 200 mM KCl. Recombinant M. tuberculosis R2-2 was then eluted with 20 ml of buffer A containing 300 mM KCl and concentrated in an Amicon concentrator. Concentrated recombinant M. tuberculosis R2-2 was diluted threefold with buffer A to reduce the salt concentration, concentrated one more time, and stored at Ϫ70°C.
Western blotting. Proteins were separated on an SDS-12% polyacrylamide gel, transferred onto a nitrocellulose membrane (34), incubated with polyclonal rabbit anti-M. tuberculosis R2-2 antibodies, and developed by using the ABC Vectastain kit. The polyclonal anti-M. tuberculosis R2-2 antibody was raised in rabbits by immunization with pure recombinant M. tuberculosis R2-2, and it cross-reacts with M. tuberculosis R2-1.
Peptide purification. The peptides provided by SynPep were 85% pure and were further purified with high-pressure liquid chromatography to a single peak by the standard method (octyldecyl silane 18 preparative column; 30-min linear gradient from 100% of 0.1% trifluoracetic acid (TFA) in H 2 O to 50% of 0.1% TFA in H 2 O and 50% of 0.1% TFA in CH 3 CN). The purified peptides were dissolved in distilled water, and the concentration was determined by UV absorption of the tryptophan residue at 280 nm (ε ϭ 6.2 mM Ϫ1 cm Ϫ1 ). Activity assays of recombinant M. tuberculosis RR. Activities were determined from the rate of reduction of [ 3 H]CDP. Recombinant holoenzyme was generated by mixing various ratios of recombinant R1 and R2-2. Recombinant M. tuberculosis R1 was purified from recombinant E. coli by using a dATP-Sepharose affinity column as we previously described (41) . One activity unit is defined as the formation of 1 nmol of dCDP/min; specific activity is expressed in units per milligram of protein.
The specific activity of the R2 subunit was determined by titrating a constant concentration of R2 with increasing concentrations of R1. K d , the dissociation constant for the complex, and V max for the reaction R1 dimer ϩ R2 dimerR 1 dimer R2 dimer were determined by nonlinear least-squares fitting of the data (Igor program; Wavemetrics, Lake Oswego, Oreg.) presented in Fig. 6 to the following equation:
where the free concentration of R1,
The specific activity of the R1 subunit and the binding constant for ATP activation of CDP reduction (K eff ), assuming a single ATP binding site, was determined by fitting the data presented in Fig. 7 to the following equation:
. These experiments were carried out under saturating substrate conditions and with the concentration of R1 as the limiting component.
In the peptide inhibition assays, various concentrations of peptide were added to the assay mixture and the reaction was started by the addition of the enzyme (2 g of R1 and 20 g of R2-2). The reactions were carried out under standard assay conditions (1.8 mM ATP and 0.2 mM CDP at 37°C for 10 min).
Construction of a complementation vector for M. tuberculosis R1. pTRC 99A (Pharmacia) was digested with NcoI and the 3Ј recessed ends were filled in to generate pTRC 99A Blunt, which was digested with XbaI to generate pTRC 99A (Blunt/XbaI).
PCR primers R1 N-Term/Blunt (5Ј-GTGCCACCAACCGTCATT-3Ј) and R1 C-Term/XbaI (the XbaI cloning site is underlined) (5Ј-ACGTTCTAGACTAC AGCATGCAGGACACG-3Ј) were used to amplify the R1 subunit gene. The PCRs were carried out in 100 l of a solution containing 200 ng of M. tuberculosis genomic DNA (Erdman strain), 1 M each primer, 0.2 mM each dNTP, 1ϫ Vent polymerase buffer, and 2 U of Vent DNA polymerase (New England BioLabs). Amplification conditions were 30 cycles of 20 s at 95°C, 30 s at 50°C, and 30 s at 72°C. The PCR product was digested with 100 U of XbaI at 37°C for 6 h. Construction of a complementation vector (pSC1) for R2-2 and R2-1. pA-CYC177 (New England BioLabs) was digested with AatII and BglI, and the fragment from position 422 to 3561 was purified. PCR primers lacI q /AatII (with the AatII site underlined) (5Ј-ATCGGACGTCGCGCGAAGGCGAAGC-3Ј) and rrnB/BglI (with the BglI site underlined) (5Ј-ATCGGCCGGAAGGGCAA GAGTTTGTAGAAACGCC-3Ј) were used to amplify the lacI q -rrnB fragment of pTRC 99A. The PCR product was digested with BglI and AatII, ligated to the fragment of pACYC177 from position 422 to 3561, and transformed into competent DH5␣.
PCR primers R2-2/N-Term/Blunt (5Ј-GTGACTGGAAACGCAAAG-3Ј) and R2-2/C-Term/KpnI (with the KpnI site underlined) (5Ј-ATCGGGTACCCTAG AAGTCCCAGTC-3Ј), and PCR primers R2-1/N-Term/Blunt (5Ј-ATGACCGG CAAGCTCGTTG-3Ј) and R2-1/C-Term/KpnI (5Ј-ATCGGGTACCTTAGAA GTCCCAGTC-3Ј), were used to amplify the R2-2 and R2-1 genes, respectively.
Construction of recombinant M. tuberculosis R2-2Y110F. Two sets of PCR primers were designed to replace tyrosine with phenylalanine at position 110, corresponding to the tyrosyl radical at position 122 in E. coli R2. PCR primers R2-2/N-Term/Blunt (5Ј-GTGACTGGAAACGCAAAG-3Ј) and Tyr3Phe Bottom (5Ј-GATCTGGCTGAAGCTCTTGG-3Ј) were used to amplify amino acid residues 1 through 113 with a Phe introduced at residue 110. PCR primers R2-2/C-Term/KpnI (5Ј-ATCGGGTACCCTAGAAGTCCCAGTC-3Ј) and Tyr3Phe Top (with the mutated residue underlined) (5Ј-GCCAAGAGCT TCAGCCAGATC-3Ј) were used to amplify amino acid residues 107 to 325 (the C terminus). The 339-and 654-bp PCR products were gel purified and pooled, and the full-length gene for R2-2Y110F was amplified by using primers R2-2/ N-Term/Blunt and R2-2/C-Term/KpnI. The gene encoding R2-2Y110F was inserted into pSC1 as described above.
Complementation of a nrdA(Ts) strain of E. coli. E. coli E101 (thr-1 leuB6 lacY1 glnV44(AS) Ϫ rfbD1 nrdA1(Ts) thyA6 rpsL67 thi-1 deoB37 deoC1) (10), obtained from the E. coli Genetic Stock Center (Dept. of Biology, Yale University), in which the nrdA gene product is temperature sensitive and which is unable to grow at 42°C, was grown in 2YT (yeast tryptone) medium in the presence of 25 mg of streptomycin/ml. Transformation was carried out with a Bio-Rad electroporator according to the manufacturer's suggested protocol, and the cells were plated on selective media: 25 mg of streptomycin/ml, 50 mg of kanamycin/ ml, and 100 mg of ampicillin/ml for the doubly transformed cells. Induction was carried out with 1 mM IPTG.
Expression of M. tuberculosis RR subunits in E. coli E101. Transformed E101 organisms were grown at 30°C to an optical density at 600 nm of 0.6 and were induced with 1 mM IPTG for 2 h at 30°C. The cells were harvested and washed with solution A (50 mM Tris-HCl [pH 7.6], 10 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride), resuspended in 400 l of solution A, and sonicated for 20 s at 50 W. The insoluble material was separated from the soluble extract by centrifugation, and the pellet was resuspended in solution A.
EPR spectra of recombinant M. tuberculosis R2-2. Spectra of recombinant M. tuberculosis R2-2 (6 mg/ml in 200 mM KCl) were obtained at 5 K by using a Bruker ESP300 spectrometer coupled with an Oxford helium flow cryostat. The spectrum was acquired with a microwave power of 1 W, a frequency of 9.62 GHz, a modulation frequency of 100 kHz, a modulation amplitude of 1.92 G, a time constant of 40.96 ms, receiver gain of 1.00 ϫ 10 4 , and a scan time of 655 s. The spectrum was collected at the electron paramagnetic resonance (EPR) facility, Stockholm University, in collaboration with Astrid Gräslund and Aimin Liu.
Nucleotide sequence accession numbers. The GenBank accession no. for M. tuberculosis R2-1 is U41099, and that for M. tuberculosis R2-2 is U41100.
RESULTS AND DISCUSSION
Isolation of M. tuberculosis R2-1 and R2-2 genes. Two distinct PCR products of 200 and 300 bp were generated from genomic M. tuberculosis DNA with primers designed from conserved regions of S. typhimurium nrdF as described above. Although the two PCR products have a common 5Ј primer, sequence analysis showed that they were not identical. This suggested that there may be two R2 genes in M. tuberculosis. A Southern blot of high-molecular-weight M. tuberculosis DNA cleaved with either XbaI, SacI, NotI, or EcoRI (Fig. 1) was probed with the 200-bp (Fig. 1A) and with the 300-bp (Fig. 1B) PCR fragment. The results of the Southern blots of genomic M. tuberculosis DNA suggested the existence of two R2 genes (Fig. 1C) . In fact, a complete R2 coding sequence (designated R2-1) was found to be contained within the 4-kb SacI fragment and a different complete R2 coding sequence (designated R2-2) was contained within the 6-kb EcoRI fragment. There was 71% homology at the DNA level between the two genes and 71% identity in the derived amino acid sequence. The genes encoding M. tuberculosis R2-1 and R2-2 will be designated nrdF1 and nrdF2, respectively.
Analysis of GenBank revealed that the gene encoding M. tuberculosis R2-1 (nrdF1) is contained on cosmids Y39 from the Sanger Centre and MBU34849 (accession no. Z74025 and U34849, respectively). The numbering system of the Y39 cosmid (39,415 bp) is used as a reference. nrdF1 starts at position 36483, and the stop codon is at position 37451. Based on a computer-generated restriction analysis of Y39, SacI sites at positions 34124 and 38442 generate the 4,318-bp fragment seen on the blot. A single EcoRI site is found at position 30421, and no other EcoRI site is identified in the remaining length of the cosmid. Therefore, the 6,000-bp fragment clearly seen on the blot must correspond to another region of the M. tuberculosis genome where nrdF2 resides. A NotI site occurs at position 35906, upstream from the start codon of nrdF1, on Y39, and there are no additional NotI sites in the remaining length of the cosmid, indicating that a band should be seen at a size in excess of 3,500 bp, depending upon the location of the downstream site. This is the 4. In order to determine the generality of the nrdF1/nrdF2 finding, we carried out a PCR experiment using DNA from four additional strains of M. tuberculosis (CSU 11, CSU 17, CSU 20, and CSU 22) (Fig. 1D) . Based on the differences in sequence, PCR primers were designed that amplify only nrdF1 or nrdF2, as demonstrated by specific PCR signals arising from the nrdF1 and nrdF2 expression plasmids. The primers generated specific PCR products of the correct size for nrdF1 and nrdF2 from all four strains of M. tuberculosis. After this work was completed however, the TIGR databank (http://www .tigr.org) was released; M. tuberculosis nrdF2 was located on gnlTIGRgmt125, and M. tuberculosis nrdF1 was located on gnlTIGRgmt435.
The coding region of M. tuberculosis R1 is GC rich, consisting of 30.2% G and 28.7% C. The coding regions of M. tuberculosis R2-1 (27.2% G and 31.9% C) and MTb R2-2 (29.5% G and 30.7% C) are equally GC rich, as are the upstream sequences of 1,200 nucleotides (30.2% G and 31.5%C for R2-1; 31.7% G and 32.2% C for R2-2) and the downstream regions of 1,287 nucleotides (30.5% G and 32.7% C for R2-1; 33.4% G and 30.9% C for R2-2).
M. tuberculosis R2-1 was 65% identical, and M. tuberculosis R2-2 was 71% identical, to the S. typhimurium nrdF gene product. This is in contrast to 21 to 23% identity to the E. coli nrdB gene product and approximately 16% identity with the human R2 subunit. M. tuberculosis R2-2 appears to use a GTG-encoded methionine as the start codon.
Alignment of the two derived M. tuberculosis R2 polypeptides with S. typhimurium R2F and with Bacillus subtilis, Mycoplasma genitalium, and E. coli R2 (Fig. 2) demonstrate that both M. tuberculosis R2s contain the conserved radical tyrosine corresponding to residue 122 in E. coli R2. The iron-binding residues, corresponding to Asp84, Glu115, His118, Glu204, Glu238, and His241 in E. coli R2, are conserved in both M. tuberculosis R2s. The residues, corresponding to Phe208, Phe212, Ile234, and Tyr122 in E. coli R2, that form the hydrophobic pocket into which the O 2Ϫ (the -oxo bridge) projects are also conserved in both M. tuberculosis R2s. It has been proposed that these conserved residues are essential for maintaining R2 as a functional cofactor for the catalytic R1 subunit (23, 26) . The extensive hydrogen-bonded network of amino acids postulated to play a role in the radical transfer reaction in the E. coli nrdAB system includes residues Tyr122, Asp84, His118, Asp237, Trp48, and Tyr356 in R2 and Tyr730, Tyr731, and Cys439 in R1 (5). These residues are conserved in the proteins encoded by M. tuberculosis nrdE, nrdF1, and nrdF2. Therefore, either M. tuberculosis R2-1 or M. tuberculosis R2-2 could, in principle, serve as a functional small subunit.
The C-terminal residues encoded by nrdF1 and nrdF2 differ from any other R2 subunits thus far identified. The C termini of the M. tuberculosis R2s are more hydrophilic and more negatively charged than that of human R2. There are six negatively charged carboxyl groups among the seven C-terminal residues, including the carboxyl group of Phe324, indicating that the binding domain on R1 carries a positive charge. The observed divergence at the C terminus between human and M. tuberculosis R2s may have an important impact on antituberculosis drug development, given the potential to develop species-specific inhibitors of RR based on the properties of these residues (20) .
M. tuberculosis R1 has recently been localized on cosmid SCY22D7, deposited in GenBank. In addition, M. tuberculosis R1 and R2 matches were found in Mycoplasma pneumoniae on MPAE 000050 and in Mycoplasma genitalium on U39701.
Gene organization of M. tuberculosis R2. Unlike other bacterial RR systems (29-32, 35, 36) Complementation. In order to further investigate the functional properties of M. tuberculosis R1, R2-1, R2-2, and a catalytically inactive variant of R2-2 (R2-2Y110F), we carried out complementation in an E. coli strain in which the nrdA gene product was temperature sensitive (E. coli E101). Based on the divergent C-terminal residues encoded by nrdB and nrdF2, we hypothesized that there would be no binding between E. coli nrdA R1 and the M. tuberculosis small subunit, nor could there be binding between E. coli nrdB R2 and the M. tuberculosis large subunit. Therefore, complementation in E. coli provides a convenient analysis of a functional M. tuberculosis RR system because in order to suppress the temperature sensitivity phenotype, both M. tuberculosis RR subunits would have to be expressed. A complementation expression system was designed where the M. tuberculosis genes for the large and small subunits were inserted into separate plasmids with different origins of replication, permitting cotransformation and expression of the genes encoding the two subunits. A variant of the small subunit was generated in which the catalytically active tyrosine was replaced by a phenylalanine which could not generate the radical. This variant is designated M. tuberculosis R2-2Y110F. In all cases, transformed E. coli E101 expressed the two subunits at the permissive temperature, as determined by Western blotting (data not shown). Recombinant M. tuberculosis R2-1 remained soluble in this system, possibly because there is only a low level of expression compared to the highexpression pET-11a system. The temperature sensitivity phenotype of E. coli E101 was suppressed by cotransformation with M. tuberculosis R1 and M. tuberculosis R2-2, whereas there was no growth at the restrictive temperature when E101 expressed M. tuberculosis R1 and either M. tuberculosis R2-1 or M. tuberculosis R2-2Y110F. It is possible that the expression of R2-1 was too low and the intracellular concentration of R2-1 was insufficient to generate active holoenzyme. No complementation was achieved when the gene for only one of the subunits was electroporated into E101. Activity and physical characterization of recombinant M. tuberculosis R2. SDS-polyacrylamide gel electrophoresis (PAGE) and Western blot analyses of crude extracts of M. tuberculosis (Fig. 3) showed two bands, corresponding to R2-1 (lanes 1) and R2-2 (lanes 3). The molecular mass of M. tuberculosis R2-1 appears to be larger than that of M. tuberculosis R2-2, which we speculate may represent a posttranslational processing event. It should be noted that the highly purified M. tuberculosis R2-1 seen on the gel was derived from the insoluble cytoplasmic inclusion body by solubilizing the pellet in 6 M guanidinium HCl, followed by dilution into buffer A, whereupon it reprecipitated. The reprecipitated material was then applied to the SDS-PAGE gel in SDS loading buffer.
In order to investigate the biochemical properties of M. tuberculosis RR, we purified recombinant R2. With the highlevel pET-11 expression system, 20 mg of soluble recombinant M. tuberculosis R2-2 was purified from a 1-liter culture (Fig. 4) . However, recombinant M. tuberculosis R2-1 was insoluble under the same conditions. Recombinant MTb R2-2 has a tyrosine radical absorption band at 408 nm that could be abolished with 15 mM hydroxyurea (Fig. 5A) . The EPR spectrum of M. tuberculosis R2-2 has a G value of 2.0056. (Fig. 5B) and is similar to that of the Salmonella nrdF-encoded R2 but quite different from that of the nrdB gene product (17) .
Purified recombinant M. tuberculosis R2-2 (40 g) alone had no catalytic activity under standard assay conditions (1.8 mM ATP and 0.2 mM CDP). When 1 g of recombinant M. tuberculosis R2-2 was titrated with recombinant M. tuberculosis R1 (0 to 32 g) in the presence of 0.2 mM CDP and 1.8 mM of ATP, the specific activity of the R2 subunit was 120 nmol of dCDP/min/mg of recombinant M. tuberculosis R2-2 (Fig. 6) . The K d for the R1-R2 complex under these assay conditions is 0.26 M. This result is similar to that found for the mammalian (15) (K d ϭ 0.12 M) and E. coli (4) (K d ϭ 0.18 M) enzymes under similar conditions. Under conditions where R1 is the limiting species, we calculated a specific activity of 25 nmol of dCDP/min/mg of recombinant M. tuberculosis R1 (Fig. 7) . It should be noted that differences in specific activity between the R1 and R2 subunits in the presence of saturating concentrations of the second subunit have been described previously (22) . dATP maximally stimulates CDP reduction by recombinant M. tuberculosis RR at approximately 75 M and remains a positive effector up to concentrations of 1 mM, similar to the Salmonella nrdEF system (Fig. 7) . NrdA large subunits contain two distinct allosteric sites. The activity site to which ATP and dATP bind can be considered an overall on-off switch-when dATP fills this site, the enzyme is inhibited, and when ATP fills the site, the enzyme is activated. The specificity site to which dGTP, dATP, dTTP, and ATP bind determines the particular nucleoside diphosphate that is reduced. For example, dATP or ATP binding to this allosteric site stimulates the reduction of CDP. In contrast to the NrdA case, analysis of nrdE sequences, including those encoding Salmonella NrdE and M. tuberculosis R1, indicates that these subunits lack 50 to 60 amino acids corresponding to the N-terminal residues of the NrdA subunits which have been postulated to contain the ATP/dATP activity site (6) . The specificity allosteric site, however, is not absent. In the M. tuberculosis RR system reported here, CDP reduction is stimulated and not inhibited by dATP, which is consistent with this prediction. The absence of a dATP activity site on M. tuberculosis R1 also implies that there will be no induction of inactive or less-active R1 tetramer formed by dATP (induction has been reported for the mammalian system [15] ).
The equilibrium constant for the activation of CDP reduction by ATP is 100 M (Fig. 7) , similar to the value of 80 M determined for E. coli RR (25) . The exact stoichiometry of ATP binding is not yet known for the M. tuberculosis system, so the value reported here is based on the conservative assumption of one equivalent of ATP binding to the active heterodimeric (R1 dimer R2 dimer ) enzyme.
Inhibition by the C-terminal peptides. It has been shown for the E. coli nrdAB, mammalian, and herpesvirus RR systems that peptides corresponding to the C-terminal tail of the R2 subunit can compete for the R2 binding site on R1 and thus inhibit RR activity (4, 9, 11, 40) . Similarly, the activity of recombinant M. tuberculosis RR was inhibited by the N-terminally acetylated peptide, R2-2 Ac-P7, corresponding to the C-terminal 7 residues of M. tuberculosis R2-2 (EDDDWDF), with a 50% inhibitory concentration (IC 50 ) of 15 to 20 M ( Table 1 ). The peptide R2-1 Ac-P7, corresponding to the Cterminal tail of M. tuberculosis R2-1 (TDTDWDF), inhibits recombinant M. tuberculosis RR with an IC 50 of 100 M (Table  1) . The IC 50 s of R2-2 Ac-P6, R2-2 Ac-P7, and R2-2 Ac-P9 are consistent with those found for the correspondingly sized peptides in the mammalian and viral RR systems. The 7-residue acetylated peptide corresponding to the human R2 subunit C-terminal tail is not an inhibitor of M. tuberculosis RR ( Table 1) . Purification of a nrdE-type-encoded R1 from M. tuberculosis, immunoblot evidence that a nrdF-type-encoded R2 is present in crude extracts of M. tuberculosis, and the lack of evidence so far for a nrdAB system suggest that the nrdEF system is the biologically active RR system in M. tuberculosis. This adds support to the recent speculation (17) that the nrdEF system could be the prevalent class I RR in microorganisms. The issue of the biological relevance of R2-1 versus R2-2 will be resolved by using allelic exchange in M. tuberculosis (1) to knock out the individual subunit genes. A determination of the complete set of allosteric parameters of RR may provide insight into the GC-rich nature of the M. tuberculosis genome, and full biochemical and biophysical characterization of this enzyme system and the analysis of the transcriptional and translational regulation of M. tuberculosis RR will be important in understanding the unusual biology of M. tuberculosis. a Two micrograms of recombinant R1 and 20 g of recombinant R2-2 were used in each assay in a final volume of 100 l in the presence of 0.2 mM CDP and 1.8 mM ATP. Ac, acetyl.
